{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:02:20Z","timestamp":1790121740457,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106353","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T21:56:21Z","timestamp":1657576581000},"page":"106353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The novel role of glucocorticoid-induced leucine zipper as a marker of mucosal healing in inflammatory bowel diseases"],"prefix":"10.1016","volume":"182","author":[{"given":"Giuseppe","family":"Leoncini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Lusenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Calaf\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Migliorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Villanacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106353_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105206","article-title":"Extra-intestinal manifestations of inflammatory bowel diseases","volume":"161","author":"Marotto","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2022.106353_bib2","unstructured":"A.N. Ananthakrishnan, G.G. Kaplan, C.N. Bernstein, K.E. Burke, P.J. Lochhead, A.N. Sasson, M. Agrawal, J.H.T. Tiong, J. Steinberg, W. Kruis, F. Steinwurz, V. Ahuja, S.C. Ng, D.T. Rubin, J.F. Colombel, R. Gearry, D. International Organization for Study of Inflammatory Bowel, Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus, Lancet Gastroenterol Hepatol (2022)."},{"key":"10.1016\/j.phrs.2022.106353_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106146","article-title":"Emerging pharmacotherapy for inflammatory bowel diseases","volume":"178","author":"Luo","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2022.106353_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105120","article-title":"Biological therapy in pediatric age","volume":"161","author":"Penagini","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2022.106353_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105075","article-title":"Inflammatory bowel disease - non-biological treatment","volume":"160","author":"Magro","year":"2020","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106353_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.giec.2019.02.004","article-title":"Treat-to-target in inflammatory bowel diseases, what is the target and how do we treat?","volume":"29","author":"Agrawal","year":"2019","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.phrs.2022.106353_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"G. Practice Parameters Committee of the American College of, Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106353_bib8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/134.6.876","article-title":"Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis","volume":"134","author":"Harpaz","year":"2010","journal-title":"Arch. Pathol. Lab Med"},{"issue":"12","key":"10.1016\/j.phrs.2022.106353_bib9","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.3748\/wjg.v20.i12.3164","article-title":"Microscopic features of colorectal neoplasia in inflammatory bowel diseases","volume":"20","author":"Bressenot","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106353_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.gtc.2006.07.007","article-title":"Pathology of dysplasia and cancer in inflammatory bowel disease","volume":"35","author":"Odze","year":"2006","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.phrs.2022.106353_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.phrs.2022.106353_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10151-020-02349-9","article-title":"Diagnostic interobserver variability in Crohn\u2019s disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group","volume":"25","author":"Leoncini","year":"2021","journal-title":"Tech. Coloproctol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106353_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.dld.2019.11.005","article-title":"Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)","volume":"52","author":"Villanacci","year":"2020","journal-title":"Dig. Liver Dis."},{"issue":"11","key":"10.1016\/j.phrs.2022.106353_bib14","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.phrs.2022.106353_bib15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn\u2019s disease","volume":"15","author":"Schnitzler","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.phrs.2022.106353_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Froslie","year":"2007","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phrs.2022.106353_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.dld.2013.06.010","article-title":"Definition and evaluation of mucosal healing in clinical practice","volume":"45","author":"Mazzuoli","year":"2013","journal-title":"Dig. Liver Dis."},{"issue":"12","key":"10.1016\/j.phrs.2022.106353_bib18","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.crohns.2014.08.011","article-title":"Systematic review: histological remission in inflammatory bowel disease. Is \u2018complete\u2019 remission the new treatment paradigm? An IOIBD initiative","volume":"8","author":"Bryant","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"4","key":"10.1016\/j.phrs.2022.106353_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"14","key":"10.1016\/j.phrs.2022.106353_bib20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1042\/CS20171505","article-title":"Defining the role of glucocorticoids in inflammation","volume":"132","author":"Ronchetti","year":"2018","journal-title":"Clin. Sci. (Lond. )"},{"issue":"2","key":"10.1016\/j.phrs.2022.106353_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.gastro.2008.09.024","article-title":"Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis","volume":"136","author":"Cannarile","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2022.106353_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.celrep.2014.03.004","article-title":"GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-beta signaling","volume":"7","author":"Bereshchenko","year":"2014","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.phrs.2022.106353_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrrheum.2011.59","article-title":"Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis","volume":"7","author":"Beaulieu","year":"2011","journal-title":"Nat. Rev. Rheuma"},{"issue":"1","key":"10.1016\/j.phrs.2022.106353_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010122","article-title":"GILZ as a regulator of cell fate and inflammation","volume":"11","author":"Bruscoli","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2022.106353_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2003-12-4295","article-title":"GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis","volume":"104","author":"Asselin-Labat","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2022.106353_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104842","article-title":"Glucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance","volume":"158","author":"Vago","year":"2020","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106353_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059149","article-title":"Glucocorticoid-induced leucine zipper (GILZ) regulates testicular FOXO1 activity and spermatogonial stem cell (SSC) function","volume":"8","author":"Ngo","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.phrs.2022.106353_bib28","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M704147200","article-title":"Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ)","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2022.106353_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jcmm.15913","article-title":"Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction","volume":"25","author":"Cappetta","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.phrs.2022.106353_bib30","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1038\/s41598-017-07338-x","article-title":"Usefulness of different pathological scores to assess healing of the mucosa in inflammatory bowel diseases: a real life study","volume":"7","author":"Villanacci","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2022.106353_bib31","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/den.13863","article-title":"The endoscopic diagnosis of mucosal healing and deep remission in inflammatory bowel disease","volume":"33","author":"Moriichi","year":"2021","journal-title":"Dig. Endosc."},{"issue":"11","key":"10.1016\/j.phrs.2022.106353_bib32","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ecco-jcc\/jjy092","article-title":"Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa","volume":"12","author":"Ozaki","year":"2018","journal-title":"J. Crohns Colitis"},{"issue":"11","key":"10.1016\/j.phrs.2022.106353_bib33","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/ajg.2012.301","article-title":"Hertogh, Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing","volume":"107","author":"Bessissow","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106353_bib34","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/gutjnl-2018-317571","article-title":"Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis","volume":"68","author":"van der Post","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.phrs.2022.106353_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2002-02-0538","article-title":"Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10","volume":"101","author":"Berrebi","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2022.106353_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/JLB.3AB0718-255R","article-title":"GILZ restrains neutrophil activation by inhibiting the MAPK pathway","volume":"105","author":"Ricci","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"44","key":"10.1016\/j.phrs.2022.106353_bib37","doi-asserted-by":"crossref","first-page":"22949","DOI":"10.1074\/jbc.M116.733253","article-title":"Induction of glucocorticoid-induced leucine zipper (GILZ) contributes to anti-inflammatory effects of the natural product curcumin in macrophages","volume":"291","author":"Hoppstadter","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2022.106353_bib38","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood-2005-07-2760","article-title":"GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response","volume":"107","author":"Cohen","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.phrs.2022.106353_bib39","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1096\/fj.201601315R","article-title":"Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression","volume":"31","author":"Ricci","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2022.106353_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105779","article-title":"Neutrophil extracellular traps in inflammatory bowel diseases: implications in pathogenesis and therapeutic targets","volume":"171","author":"Dos Santos Ramos","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2022.106353_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105050","article-title":"Controlling leukocyte trafficking in IBD","volume":"159","author":"Veny","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2022.106353_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105040","article-title":"Targeting T cells in inflammatory bowel disease","volume":"159","author":"Giuffrida","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2022.106353_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fendo.2015.00170","article-title":"GILZ as a mediator of the anti-inflammatory effects of glucocorticoids","volume":"6","author":"Ronchetti","year":"2015","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.phrs.2022.106353_bib44","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100778RRRR","article-title":"A recombinant glucocorticoid-induced leucine zipper protein ameliorates symptoms of dextran sulfate sodium-induced colitis by improving intestinal permeability","volume":"35","author":"Gentili","year":"2021","journal-title":"FASEB J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:44:07Z","timestamp":1760913847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"alternative-id":["S1043661822002985"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106353","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel role of glucocorticoid-induced leucine zipper as a marker of mucosal healing in inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106353"}}